Phox2B is a sensitive and reliable marker of paraganglioma-Phox2B immunohistochemistry in diagnosis of neuroendocrine neoplasms.

Chromaffin cell GATA3 Neuroendocrine neoplasms Olfactory neuroblastoma Paraganglioma Phox2B Well differentiated neuroendocrine tumours

Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 07 09 2022
accepted: 09 01 2023
revised: 14 12 2022
medline: 4 4 2023
pubmed: 20 1 2023
entrez: 19 1 2023
Statut: ppublish

Résumé

Phox2B is a transcription factor responsible for chromaffin cell phenotype. Although it is used routinely for diagnosis of neuroblastoma, previous reports concerning its utility in the diagnosis of neuroendocrine neoplasms have been conflicting. We assessed Phox2b immunoreactivity in different neuroendocrine neoplasms. Tissue microarrays or whole sections of 36 paragangliomas (PGs), 91 well-differentiated neuroendocrine tumours of different organs (WDNETs), 31 neuroendocrine carcinomas (NECs), and 6 olfactory neuroblastomas (ONBs) were stained with Phox2B antibody (EP312) and GATA3. The percentage of positive cells and intensity was analysed using H-score. Phox2B immunoreactivity was seen in 97.2% (35/36) PGs, 11% (10/91) WDNETs, 9.7% (3/31) NECs, and 16.7% (1/6) ONBs. PGs were significantly more often positive (p < 0.001, χ

Identifiants

pubmed: 36656393
doi: 10.1007/s00428-023-03490-0
pii: 10.1007/s00428-023-03490-0
doi:

Substances chimiques

Biomarkers, Tumor 0
Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

679-686

Subventions

Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : NV19-01-00435
Organisme : BBMRI-CZ
ID : LM2018125
Organisme : European Regional Development Fund-Project BBMRI-CZ.: Biobank network
ID : EF16_013/0001674
Organisme : Univerzita Karlova v Praze
ID : DIAG
Organisme : Univerzita Karlova v Praze
ID : METD

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Asa SL, Mete O (2021) Cytokeratin profiles in pituitary neuroendocrine tumors. Hum Pathol 107:87–95. https://doi.org/10.1016/j.humpath.2020.10.004
doi: 10.1016/j.humpath.2020.10.004 pubmed: 33098891
Beumer J, Puschhof J, Bauza-Martinez J, Martinez-Silgado A, Elmentaite R, James KR, Ross A, Hendriks D, Artegiani B, Busslinger GA, Ponsioen B, Andersson-Rolf A, Saftien A, Boot C, Kretzschmar K, Geurts MH, Bar-Ephraim YE, Pleguezuelos-Manzano C, Post Y, Begthel H, van der Linden F, Lopez-Iglesias C, van de Wetering WJ, van der Linden R, Peters PJ, Heck AJR, Goedhart J, Snippert H, Zilbauer M, Teichmann SA, Wu W, Clevers H (2020) High-resolution mRNA and secretome atlas of human enteroendocrine cells. Cell 182:1062–1064. https://doi.org/10.1016/j.cell.2020.08.005
doi: 10.1016/j.cell.2020.08.005 pubmed: 32822568
Bielle F, Freneaux P, Jeanne-Pasquier C, Maran-Gonzalez A, Rousseau A, Lamant L, Paris R, Pierron G, Nicolas AV, Sastre-Garau X, Delattre O, Bourdeaut F, Peuchmaur M (2012) PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors. Am J Surg Pathol 36:1141–1149. https://doi.org/10.1097/PAS.0b013e31825a6895
doi: 10.1097/PAS.0b013e31825a6895 pubmed: 22790854
Borges M, Linnoila RI, van de Velde HJ, Chen H, Nelkin BD, Mabry M, Baylin SB, Ball DW (1997) An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 386:852–855. https://doi.org/10.1038/386852a0
doi: 10.1038/386852a0 pubmed: 9126746
Drabent P, Bonnard A, Guimiot F, Peuchmaur M, Berrebi D (2020) PHOX2B immunostaining: a simple and helpful tool for the recognition of ganglionic cells and diagnosis of Hirschsprung disease. Am J Surg Pathol 44:1389–1397. https://doi.org/10.1097/PAS.0000000000001528
doi: 10.1097/PAS.0000000000001528 pubmed: 32604166
Furlan A, Dyachuk V, Kastriti ME, Calvo-Enrique L, Abdo H, Hadjab S, Chontorotzea T, Akkuratova N, Usoskin D, Kamenev D, Petersen J, Sunadome K, Memic F, Marklund U, Fried K, Topilko P, Lallemend F, Kharchenko PV, Ernfors P, Adameyko I (2017) Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla. Science. https://doi.org/10.1126/science.aal3753
Gehart H, van Es JH, Hamer K, Beumer J, Kretzschmar K, Dekkers JF, Rios A, Clevers H (2019) Identification of enteroendocrine regulators by real-time single-cell differentiation mapping. Cell 176(1158–1173):e1116. https://doi.org/10.1016/j.cell.2018.12.029
doi: 10.1016/j.cell.2018.12.029
Hata JL, Correa H, Krishnan C, Esbenshade AJ, Black JO, Chung DH, Mobley BC (2015) Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow. Arch Pathol Lab Med 139:543–546. https://doi.org/10.5858/arpa.2014-0255-OA
doi: 10.5858/arpa.2014-0255-OA pubmed: 25822764
Huber K, Karch N, Ernsberger U, Goridis C, Unsicker K (2005) The role of Phox2B in chromaffin cell development. Dev Biol 279:501–508. https://doi.org/10.1016/j.ydbio.2005.01.007
doi: 10.1016/j.ydbio.2005.01.007 pubmed: 15733675
Kimura N, Shiga K, Kaneko K, Sugisawa C, Katabami T, Naruse M (2020) The diagnostic dilemma of GATA3 immunohistochemistry in pheochromocytoma and paraganglioma. Endocr Pathol 31:95–100. https://doi.org/10.1007/s12022-020-09618-1
doi: 10.1007/s12022-020-09618-1 pubmed: 32303954
Lan MS, Breslin MB (2009) Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation. FASEB J 23:2024–2033. https://doi.org/10.1096/fj.08-125971
doi: 10.1096/fj.08-125971 pubmed: 19246490 pmcid: 2704596
Lee JP, Hung YP, O′Dorisio TM, Howe JR, Hornick JL, Bellizzi AM (2017) Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas. Histopathology 71:503–510. https://doi.org/10.1111/his.13243
doi: 10.1111/his.13243 pubmed: 28464318 pmcid: 5597462
Mamilla D, Manukyan I, Fetsch PA, Pacak K, Miettinen M (2020) Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors. Hum Pathol 103:72–82. https://doi.org/10.1016/j.humpath.2020.07.010
doi: 10.1016/j.humpath.2020.07.010 pubmed: 32668278 pmcid: 7530041
Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR (2022) Tischler A (2022) Overview of the WHO Classification of Paragangliomas and Pheochromocytomas. Endocr Pathol 33:90–114. https://doi.org/10.1007/s12022-022-09704-6
doi: 10.1007/s12022-022-09704-6 pubmed: 35285002
Mete O, Kefeli M, Caliskan S, Asa SL (2019) GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors. Mod Pathol 32:484–489. https://doi.org/10.1038/s41379-018-0167-7
doi: 10.1038/s41379-018-0167-7 pubmed: 30390035
Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, Langfort R, Waloszczyk P, Biernat W, Lasota J, Wang Z (2014) GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol 38:13–22. https://doi.org/10.1097/PAS.0b013e3182a0218f
doi: 10.1097/PAS.0b013e3182a0218f pubmed: 24145643 pmcid: 3991431
Miyauchi M, Akashi T, Furukawa A, Uchida K, Tamura T, Ando N, Kirimura S, Shintaku H, Yamamoto K, Ito T, Miura K, Kayamori K, Ariizumi Y, Asakage T, Kudo A, Tanabe M, Fujii Y, Ishibashi H, Okubo K, Murakami M, Yamada T, Takemoto A, Bae Y, Eishi Y, Ohashi K (2022) PHOX2B is a sensitive and specific marker for the histopathological diagnosis of pheochromocytoma and paraganglioma. Endocr Pathol. https://doi.org/10.1007/s12022-022-09730-4
Nonaka D, Wang BY, Edmondson D, Beckett E, Sun CC (2013) A study of gata3 and phox2b expression in tumors of the autonomic nervous system. Am J Surg Pathol 37:1236–1241. https://doi.org/10.1097/PAS.0b013e318289c765
doi: 10.1097/PAS.0b013e318289c765 pubmed: 23715162
Ordonez NG (2014) Value of GATA3 immunostaining in the diagnosis of parathyroid tumors. Appl Immunohistochem Mol Morphol 22:756–761. https://doi.org/10.1097/PAI.0000000000000007
doi: 10.1097/PAI.0000000000000007 pubmed: 25046229
Simoes-Costa M, Bronner ME (2015) Establishing neural crest identity: a gene regulatory recipe. Development 142:242–257. https://doi.org/10.1242/dev.105445
doi: 10.1242/dev.105445 pubmed: 25564621 pmcid: 4302844
Soukup J, Manethova M, Kohout A, Soukup T, Dvorakova R, Drugda J, Vitovcova B, Gabalec F, Kaiser M, Kanta M, Kasparova P, Kozak J, Michnova L, Netuka D, Reguli S, Rychly B, Trnkova M, Vachata P, Wozniakova M, Cesak T (2022) Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors. Virchows Arch. https://doi.org/10.1007/s00428-022-03441-1
Uccella S, Facco C, Chiaravalli AM, Pettenon F, La Rosa S, Turri-Zanoni M, Castelnuovo P, Cerati M, Sessa F (2022) Transcription factor expression in sinonasal neuroendocrine neoplasms and olfactory neuroblastoma (ONB): Hyams’ grades 1–3 ONBs expand the spectrum of SATB2 and GATA3-positive neoplasms. Endocr Pathol 33:264–273. https://doi.org/10.1007/s12022-022-09715-3
doi: 10.1007/s12022-022-09715-3 pubmed: 35522392 pmcid: 9135868
Unsicker K, Huber K, Schober A, Kalcheim C (2013) Resolved and open issues in chromaffin cell development. Mech Dev 130:324–329. https://doi.org/10.1016/j.mod.2012.11.004
doi: 10.1016/j.mod.2012.11.004 pubmed: 23220335
Vermeiren S, Bellefroid EJ, Desiderio S (2020) Vertebrate sensory ganglia: common and divergent features of the transcriptional programs generating their functional specialization. Front Cell Dev Biol 8:587699. https://doi.org/10.3389/fcell.2020.587699
doi: 10.3389/fcell.2020.587699 pubmed: 33195244 pmcid: 7649826
Warren M, Matsuno R, Tran H, Shimada H (2018) Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients. Histopathology 72:685–696. https://doi.org/10.1111/his.13412
doi: 10.1111/his.13412 pubmed: 28986989
Wildner H, Gierl MS, Strehle M, Pla P, Birchmeier C (2008) Insm1 (IA-1) is a crucial component of the transcriptional network that controls differentiation of the sympatho-adrenal lineage. Development 135:473–481. https://doi.org/10.1242/dev.011783
doi: 10.1242/dev.011783 pubmed: 18094025

Auteurs

Monika Manethova (M)

The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Králové, Czech Republic.

Lucie Gerykova (L)

The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Králové, Czech Republic.

Hana Faistova (H)

The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Králové, Czech Republic.

Jan Drugda (J)

4th Department of Internal Medicine, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic.

Maria Hacova (M)

Department of Pathology, The Regional Hospital Pardubice, Pardubice, Czech Republic.

Helena Hornychova (H)

The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Králové, Czech Republic.

Ales Ryska (A)

The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Králové, Czech Republic.

Filip Gabalec (F)

4th Department of Internal Medicine, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic.

Jiri Soukup (J)

The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Králové, Czech Republic. 2jiri.soukup@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH